These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 11108805

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145.
    Cattaneo-Pangrazzi RM, Schott H, Schwendener RA.
    Prostate; 2000 Sep 15; 45(1):8-18. PubMed ID: 10960838
    [Abstract] [Full Text] [Related]

  • 4. 5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
    Strasser S, Maier S, Leisser C, Saiko P, Madlener S, Bader Y, Bernhaus A, Gueorguieva M, Richter S, Mader RM, Wesierska-Gadek J, Schott H, Szekeres T, Fritzer-Szekeres M, Krupitza G.
    Differentiation; 2006 Dec 15; 74(9-10):488-98. PubMed ID: 17177846
    [Abstract] [Full Text] [Related]

  • 5. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.
    McGinn CJ, Miller EM, Lindstrom MJ, Kunugi KA, Johnston PG, Kinsella TJ.
    Int J Radiat Oncol Biol Phys; 1994 Nov 15; 30(4):851-9. PubMed ID: 7960987
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC.
    Maier S, Strasser S, Saiko P, Leisser C, Sasgary S, Grusch M, Madlener S, Bader Y, Hartmann J, Schott H, Mader RM, Szekeres T, Fritzer-Szekeres M, Krupitza G.
    Apoptosis; 2006 Mar 15; 11(3):427-40. PubMed ID: 16538382
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
    Rauko P, Novotny L, Mego M, Saiko P, Schott H, Szekeres T.
    Neoplasma; 2007 Mar 15; 54(1):68-74. PubMed ID: 17203895
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells.
    Saiko P, Horvath Z, Illmer C, Madlener S, Bauer W, Hoechtl T, Erlach N, Grusch M, Krupitza G, Mader RM, Jaeger W, Schott H, Agarwal RP, Fritzer-Szekeres M, Szekeres T.
    Leuk Res; 2005 Jul 15; 29(7):785-91. PubMed ID: 15927674
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and one-electron reduction characteristics of radiation-activated prodrugs possessing two 5-fluorodeoxyuridine units.
    Tanabe K, Sugiura M, Ito T, Nishimoto S.
    Bioorg Med Chem; 2012 Sep 01; 20(17):5164-8. PubMed ID: 22847019
    [Abstract] [Full Text] [Related]

  • 11. Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization.
    Flanagan SA, Cooper KS, Mannava S, Nikiforov MA, Shewach DS.
    Int J Radiat Oncol Biol Phys; 2012 Dec 01; 84(5):e613-20. PubMed ID: 22867891
    [Abstract] [Full Text] [Related]

  • 12. Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity.
    Canman CE, Tang HY, Normolle DP, Lawrence TS, Maybaum J.
    Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10474-8. PubMed ID: 1438236
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.
    Ren Q, Kao V, Grem JL.
    Clin Cancer Res; 1998 Nov 01; 4(11):2811-8. PubMed ID: 9829747
    [Abstract] [Full Text] [Related]

  • 14. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M, Wagner MW, Hwang HS, Kinsella TJ, Boothman DA.
    Cancer Res; 2001 Jul 01; 61(13):5193-201. PubMed ID: 11431359
    [Abstract] [Full Text] [Related]

  • 15. 5-fluoro-2'-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells.
    Parsels LA, Parsels JD, Tai DC, Coughlin DJ, Maybaum J.
    Cancer Res; 2004 Sep 15; 64(18):6588-94. PubMed ID: 15374972
    [Abstract] [Full Text] [Related]

  • 16. Genetic variation in thymidylate synthase confers resistance to 5-fluorodeoxyuridine.
    Hughey CT, Barbour KW, Berger FG, Berger SH.
    Adv Exp Med Biol; 1993 Sep 15; 339():67-76. PubMed ID: 8178730
    [Abstract] [Full Text] [Related]

  • 17. Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells.
    Murakami Y, Kazuno H, Emura T, Tsujimoto H, Suzuki N, Fukushima M.
    Int J Oncol; 2000 Aug 15; 17(2):277-83. PubMed ID: 10891536
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo antitumor activity of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
    Saiko P, Horvath Z, Bauer W, Hoechtl T, Grusch M, Krupitza G, Rauko P, Mader RM, Jaeger W, Schott H, Novotny L, Fritzer-Szekeres M, Szekeres T.
    Int J Oncol; 2004 Aug 15; 25(2):357-64. PubMed ID: 15254732
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.